Novel synthesis of Oxadiazoles via palladium catalysis

Tetrahedron Letters

Volumn 39, Issue 23, 1998, Pages 3931-3934

  Young, Jonathan R ^a   DeVita, Robert J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; IODIDE; OXADIAZOLE DERIVATIVE; OXIME; PALLADIUM;

ARTICLE; CATALYSIS; DRUG SYNTHESIS; ELECTRON;

EID: 0032482498     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)00719-9     Document Type: Article

References (21)

1. 1. (a) Borg, S.; Estenne-Bouhtou, G.; Luthman, K.; Csoregh, I. Hesselink, W.; Hacksell, U. J. Org. Chem. 1995, 60, 3112, and references cited therein.
2. (b) Andersen, K.E.; Jorgensen, A.S.; Braestrup, C. Eur. J. Med. Chem. 1994, 29, 393. For examples of improved in vivo properties, see references 2-5 therein.
3. 2. Clapp, L.B. Adv. Heterocycl. Chem. 1976, 65.
4. 3. (a) Orlek, B.S.; Blaney, F.E.; Brown, F.; Clark, M.S.G.; Hadley, M.S.; Hatcher, J.; Riley, G.J.; Rosenberg, H.E.; Wadsworth, H.J.; Wyman, P.; J. Med. Chem. 1991, 34, 2726.
5. (b) Watjen, F.; Baker, R.; Engelstoff, M.; Herbert, R.; MacLeod, A.; Knight, A.; Merchant, K.; Moseley, J.; Saunders, J.; Swain, C.J.; Wong, E.; Springer, J.P. J. Med. Chem. 1989, 32, 2282.
6. (c) Carroll, F.I.; Gray, J.L.; Abrahm, P.; Kuzemko, M.A.; Lewin, A.H.; Boja, J.W.; Kuhar, M.J. J. Med. Chem. 1993, 36, 2886.
7. (d) Diana, G.D.; Volkots, D.L.; Nitz, T.J.; Bailey, T.R.; Long, M.A.; Vescio, N.; Aldous, S.; Pevear, D.C.; Dutko, F.J. J. Med. Chem. 1994, 37, 2421.
8. (e) Ankersen, M.; Peschke, B.; Hansen, B.S.; Hansen, T.K. Bioorg. Med. Chem. Lett. 1997, 7, 1293.
9. (f) Chen, C.; Senanayake, C.H.; Bill, T.J.; Larsen, R.D.; Verhoeven, T.R.; Reider, P.J. J. Org. Chem. 1994, 59, 3738.
10. 4. (a) LaMattina, J.L.; Mularski, C. J. Org. Chem. 1984, 49, 4800.
11. (b) Steglich, W.; vanRee, T. Synth. Commun. 1982, 12, 457.
12. 5. (a) Chiou, S.; Shine, H.J. J. Heterocycl. Chem. 1989, 26, 125.
13. (b) Tiemann, F.; Kruger, P. Chem. Ber. 1884, 17, 1685.
14. 6. Claisse, J.A.; Foxton, M.W.; Gregory, G.I.; Sheppard, A.H.; Tiley, E.P.; Warburton, W.K.; Wilson, M.J. J. Chem. Soc. Perkin I 1973, 2241.
15. 7. Kim, C-K.; Zielinski, P.A.; Maggiulli, C.A. J. Org. Chem. 1984, 49, 5247.
16. 8. For a description of the mechanism, see: Ooi, N.S.; Wilson, D.S. J. Chem. Soc. Perkin II 1980, 1792.
17. 9. Liang, G.B.; Feng, D.D. Tetrahedron Lett. 1996, 37, 6627.
18. 10. Schoenberg, A.; Heck, R.F. J. Org. Chem. 1974, 39, 3327.
19. 3) 2.50 (s, 3H), 3.97 (s, 3H), 8.15-8.25 (m, 4H); EIMS m/z: 218, 187, 162, 130, 102.
20. 12. An aryliodide, possessing an N-BOC protected piperidine, was subjected to the optimized conditions which provided the oxadiazole in 65% yield with no evidence of BOC-deprotection: Young, J.R. unpublished results.
21. 13. Cacchi, S.; Lupi, A. Tetrahedron Lett. 1992, 33, 3939.